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Malaria in the Greater Mekong Subregion (GMS) is heterogeneous in both space and time (Cui, Yan, 34 Sattabongkot, . Most symptomatic malaria is seasonal and the disease clusters along 35 international borders ( have been decreasing over the last several decades. However, parasites are developing resistance to the 39 first line of antimalarials (Phyo et al., 2016) , presenting a public health emergency in the current 40 absence of appropriate replacement therapies. One proposed solution to this problem is the elimination 41 of P. falciparum parasites while prevalence is low and while combination therapies remain effective in 42 clearing low density infections (von Seidlein & Dondorp, 2015) . 43
The foundation of malaria elimination programs is the provision of access to early diagnosis and 44 treatment (EDT) to all affected communities (Jordi Landier et al., 2016) . Throughout the GMS this has 45 been facilitated through programs which employ village or community health workers (Carrara et al., 46 2006); a system that has existed in parts of the GMS for over 50 years (especially in Thailand, Vietnam 47
and China) (Kauffman & Myers, 1997; Lehmann & Sanders, 2007; Zhang & Unschuld, 2008) . Infected and 48 symptomatic individuals who quickly seek and receive early diagnosis and treatment have reduced 49 infectious periods, leading to a reduction in transmission. 50
Recent work from several different parts of the GMS found several populations with high asymptomatic 51 malaria prevalence (Imwong et al., 2015) . Asymptomatic individuals are not treated and serve as a 52 reservoir for persistence of malaria in the region even in the presence of strong healthcare systems. 53 Therefore, another key tool in the elimination portfolio is targeted mass drug administration (MDA). 54 MDA includes the administration of antimalarials to all individuals in a targeted population, in this case 55 in communities that have high malaria prevalence (von Seidlein & Dondorp, 2015) . There is likely to be a 56 critical threshold for MDA coverage, below which the reduction of the parasite reservoir is not sufficient 57 to halt ongoing transmission. However, there is little empirical evidence of such coverage effects. 58
Here we describe geographic and epidemiologic patterns of clinical and subclinical P. falciparum and P. 59 vivax infections in villages receiving targeted MDA. We investigate associations between heterogeneous 60 adherence to MDA, mosquito vector biting rates, asymptomatic infections, and clinical malaria episodes. 61
To our knowledge this is the first subvillage level spatiotemporal analysis of malaria incidence and 62
prevalence from an any MDA study. 63
METHODS 64

Study location and design 65
The study site consisted of four villages (KNH, TPN, HKT, and TOT) along the Myanmar-Thailand border, 66
in Kayin (Karen) State, Myanmar (Jordi Landier et al., 2017). The villages were selected based on malaria 67 prevalence estimates from a preliminary survey in the area (Imwong et al., 2015) and were part of a 68
MDA pilot study (Jordi Landier et al., 2017) . The northernmost village is approximately 105 km from the 69 southernmost and the two closest villages, KNH and TPN are within 10km of each other (Figure 1) . The 70 study was conducted from May 2013 through June 2015. 71 A full population census was completed in each of the four study villages at baseline May -June 2013. 72
Everyone enumerated in the census was given a unique identification code. Geographic coordinates 73
were collected for all houses in the four study villages and a unique identification code was assigned to 74 each house. All individuals were then linked to their respective houses. 75
Blood surveys were conducted at baseline in each village, aiming to screen all individuals above an age 76 of 9 months. Venous blood (3mL) was drawn from each participant, transported to a central laboratory 77
and analyzed using a highly sensitive quantitative PCR (uPCR) assay with a limit of detection of 22 78
parasites per mL. (Imwong et al., 2014) . Subclinical infections detected through these blood screenings 79
are hereafter referred to as uPCR-detected "infections" of either P. falciparum or P. vivax. Most of these 80 infections (86%) were asymptomatic (J. Landier et al., 2017) . 81
A community-based malaria clinic (malaria post or MP) was established in each village at the beginning 82 of the project. Villagers were trained to diagnose malaria using rapid diagnostic tests (RDTs) and to treat 83
RDT positive infections with dose-based on weight and age. The locations of MPs, catch sites and village houses are indicated in Figure 1 . 102
ANALYSIS 103
Variables 104
All individuals recorded in the census with a house address in the four study villages were included in 105 this analysis. 106
The data were aggregated into one month time steps and individuals were coded with a "1" for any 107 month in which they presented at the village MP and were diagnosed with a P. falciparum or P. vivax 108 infection. Likewise, individuals who did not have a clinical episode within a given month were coded 109 with a "0" for that respective month. Individuals who were ever diagnosed with a clinical episode or 110 uPCR detected infection (either P. falciparum or P. vivax) were likewise coded as a "1" for analyses of 111 having ever been detected by uPCR for an infection or having ever had a clinical episode during the 112 study period. 113
Individual level predictor variables included age group, gender, infection status (not infected = 0; 114 infected =1) and adherence to MDA (number of doses taken). Household level predictor variables 115 included a binary variable for whether or not another household member had a clinical episode and 116 whether or not another household member had a uPCR-detected infection. 117
The human biting rate (HBR) for primary vectors (Anopheles minimus s.l., An. maculatus s.l., and An. 118 dirus s.l.) was calculated for each month and for each catch site. HBR values were then attributed to 119 individuals based on their house location, assigning the HBR from the catch site that was geographically 120 closest to each house. 121
Neighborhood MDA adherence was calculated as the proportion of people who took no rounds of MDA 122 within 100 meters radius of each house in the study population. This proportion was calculated for each 123 house in the study villages and non-adherence proportions were then attributed to individuals based on 124 the house to which they were attributed. 125
Both HBR and neighborhood MDA variables were operationalized as tertiles (lowest third, middle third, 126
highest third, indicated in Supplementary Table 1) . 127
Exploratory spatial and temporal analyses 128
All predictor variables were explored in bivariate analyses. Unadjusted odds ratios were calculated for 129 binary predictors and Wilcox rank sum tests were calculated for continuous variables. Cumulative 130
hazards curves were used to analyze temporal patterns in infections. 131 uPCR-detected infections (from surveys) and clinical episodes (from the MPs) were mapped at the house 132 level across time. Maps were created for each village and each survey time point (M0 -M24), with 133 clinical episodes aggregated to align with surveys (i.e. M1, M2 and M3 aggregated into M3). 134
The standard distance deviation (SDD), a two-dimensional version of a normal standard deviation, was 135 used to visually analyze the distribution of clinical P. falciparum episodes for each time point in the one 136 village with sufficient P. falciparum infections (TOT). SDD are calculated by finding the mean center of all 137 points, weighted by the number of clinical episodes. The SDD is the average distance from mean center 138 (for both the x and the y plane) for all weighted points and is represented by a circular map layer 139 centered on the weighted mean with the standard distance as radius. One SDD was calculated, 140
corresponding to approximately 68% of all points falling inside of the resulting circle. Exploratory statistics and regressions were calculated using R (version 3.4.3; https://cran.r-project.org/) 161 and the "epiR", "lme4", and "survival" packages. All maps were created using ArcGIS 10.5 162 (https://www.arcgis.com/). Exploratory spatial data analysis was conducted using ArcGIS 10.5 and 163
SatScan v9.5 (https://www.satscan.org/). The neighborhood participation variable was created using 164
ArcGIS and the Python programming language (version 3. repeated clinical episodes. P. falciparum and P. vivax infections were more prevalent in males than 185 females (UOR: 2.0; CI: 1.5 -2.8 for P. falciparum and UOR: 1.7; CI: 1.4 -2.0 for P. vivax). 186
Spatiotemporal patterns in uPCR-detected infections, clinical episodes and MDA adherence 187
P. falciparum and P. vivax infections were detected in all villages at baseline (Figures 2 and 3) . These 188 infections were significantly reduced following MDA in all villages. The prevalence of P. falciparum 189 infections had reduced in two villages (villages TPN and HKT) prior to MDA. P. vivax infections returned 190 in subsequent months in most villages (as expected given that radical cure was not provided), with the 191 exception of village TPN. 192 There were statistically significant clusters of uPCR-detected P. falciparum infections in each village at 193 baseline but subsequently no significant clusters were detected (Figure 2) . Clusters of clinical P. pattern was detected at M0 (Figure 3) . Village HKT had a cluster at M3; village KNH had one persistent 202 cluster from M9 through M18; and village TOT had two clusters at M24 (Figure 2 ). Clusters of clinical P. 203
vivax episodes also lingered in village KNH (M3 through M14 (17 episodes) and then M12 through M24 204 (6 episodes)) and in village TOT (M12 through M21 (31 episodes) and M19 through M23 (18 episodes)). 205
There was a cluster of clinical P. vivax episodes in village HKT during M23 and M24 (including 23 206 episodes). 207
There were significant clusters of non-participation in the MDAs in three of the study villages (TPN, HKT 208 and TOT (Supplementary Figure 1) ). Sporadic clinical P. falciparum episodes occurred in village TOT from M6 to M9, followed by a small 212 outbreak beginning in M13 (Figure 2) . The first clinical P. falciparum episodes during this outbreak 213 occurred among villagers who lived in the cluster of non-MDA participation (Figure 4) . By M24 the 214 clinical episodes had spread through much of the village (Figure 4) . 215
Cumulative hazards plots of clinical P. falciparum episodes in village TOT illustrate the temporal patterns 216
in infections according to neighborhood MDA adherence and household clustering (Figure 5A) . The 217
proportion of individuals who had acquired a clinical P. falciparum episode began consistently increasing 218 in M12 for those living in either low or mid MDA adherence neighborhoods. P. falciparum episodes 219 among high MDA adherence neighborhoods began increasing approximately one month after the 220 increase in low adherence neighborhoods but never reached the level experienced in either mid or low 221 MDA adherence neighborhoods. 4.4% of all individuals in high MDA adherence neighborhoods had at 222 least one clinical P. falciparum episode by the end of the study period, in comparison to 7.6% in mid and 223 9.6% in low MDA adherence neighborhoods (log-rank test p-value = 0.0485; Figure 5A ). 224
Clinical P. falciparum episodes also clustered within houses. Beginning in M6, the proportion of 225 individuals who acquired P. falciparum episodes was higher among those who lived in a house with 226 someone else who had a clinical P. falciparum episode. The overall proportion of people who acquired a 227 clinical P. falciparum episode was consistently higher throughout the study period among those who 228 lived with someone else who had a clinical P. falciparum episode (log-rank test p-value < 0.0001; Figure  229 5B). 230
The increase in clinical P. falciparum episodes in M13 coincided with an increase in HBR in village TOT 231 (Figure 5C) . 232
Longitudinal analysis of clinical P. falciparum and P. vivax episodes 233
Clinical P. falciparum episodes after MDA in village TOT were most likely to occur among 5 to 14 year 234 olds (AOR: 3.0; CI: 1.2 -7.9) and participants who lived in a house with someone else who had a clinical 235 P. falciparum episode during the same month (AOR: 4.2; CI: 2.1 -8.6) ( Table 3) . Living in a neighborhood 236 with a high proportion of adherence to MDA had a protective effect, being associated with a 90% 237 decrease in the odds of having a clinical episode (AOR: 0.1; CI: 0.01 -0.51) compared to people who 238 lived in low adherence neighborhoods ( Table 1) . These effects remained after controlling for time. 239
Living in part of the village with a high HBR was also associated with increased odds of P. falciparum 240 infection. Individuals who lived in high HBR portions of the village had over two times the odds of 241 acquiring a clinical episode (AOR: 2.3; CI: 1.2 -4.5) when compared to those who lived in parts of the 242 village with a low HBR ( Table 3) . 243
Clinical P. vivax episodes also exhibited household clustering. Individuals who lived in a house with 244 someone who had a clinical P. vivax episode during the same month had over 5 times the odds of having 245 a clinical P. vivax episode when compared to those who did not live in a house with someone who had a 246 clinical P. vivax episode (AOR: 5.8; CI: 3.4 -9.9) ( Table 3) . Living in part of a village with mid or high HBR 247
was also associated with an increased odds of P. vivax infection (mid HBR -AOR: 1.6; CI: 1.1 -2.4; high 248 HBR -AOR: 1.6; CI: 1.1 -2.4). 249
Logistic regression for odds of having a uPCR-diagnosed infection after MDA 250
The strongest predictor of having a uPCR detected P. falciparum infection after MDA was also having a 251 clinical P. falciparum episode after MDA (AOR: 4.6; CI: 1.8 -11.1) ( Table 2) . uPCR detected P. vivax 252 infections occurred mostly in older children (AOR: 2.6; CI: 1.7 -4.1), adults (AOR: 2.3; CI: 1.6 -3.6) and 253 males (AOR: 1.8; CI: 1.4 -2.2) ( Table 2) . Individuals who had a clinical P. vivax episode after MDA had 254 2.7 times the odds (CI: 1.9 -3.9) and individuals who lived in a house with someone else with a uPCR 255 detected P. vivax infection had 1.5 times the odds (CI: 1.2 -2.0) of also having a uPCR detected infection 256 after MDA ( Table 2) . 257
DISCUSSION 258
The primary goal of targeted MDA in the study villages was to reduce the prevalence of uPCR-detected 259 P. falciparum. There was also a significant impact on the incidence of clinical P. falciparum episodes, also 260 as a result of MDA. This analysis shows that post-MDA clinical P. falciparum infections in one village, TOT 261 exhibited strong spatiotemporal clustering within houses in low MDA-adherence neighborhoods and 262 within portions of the village with high HBR. 263
There was no protective effect beyond the prophylactic period after taking MDA at the individual level, 264 but there was a group level effect suggesting a level of herd protection. Those who lived in 265 neighborhoods with high participation in MDA had a reduced risk of becoming infected, regardless of 266 their individual participation in MDA. This protective effect was most pronounced in the rainy season 267 following MDA (Figure 4) and corresponded to a surge in vector activity (Figure 5C ). Once the P. 268 falciparum outbreak began, there was a lag of approximately 1 month between the onset of clinical 269 episodes in neighborhoods with mid and low MDA adherence and the spread to neighborhoods with 270 high MDA adherence (Figure 5A) . However, neighborhoods with high MDA adherence never 271 experienced the same levels of infection as those with mid or low MDA adherence (Figure 5A, Table 1 ).
272
To our knowledge, this is the first documentation of a herd effect conferred of MDA for P. falciparum 273 malaria. 274 HBR was also strongly predictive of clinical P. falciparum episodes in village TOT. The increase in clinical 275 P. falciparum episodes post-MDA occurred both in areas where MDA adherence was poor and where 276 HBR was high. HBR also peaked in one other village (HKT) at the same time as in village TOT (Figure 5C) , 277 but occurred in the absence of a detectable parasite reservoir (Figure 2) and the HBR did not persist at 278 high levels. Evidence suggests that the MP in TOT was not functioning well in the first year of the study 279 (reported in (J. Landier et al., 2017) ) and this influenced the outbreak in TOT. 280
The combination of a persisting parasite reservoir and persistently high HBR (from M13 -M18) in TOT 281 likely explains the drastically different results between the study villages with regard to P.falciparum 282 malaria elimination (Figure 2) . A better functioning MP in TOT would have reduced the size of the 283 outbreak. 284
Post-MDA clinical P. vivax episodes exhibited spatiotemporal clustering within houses and within areas 285 with mid to high levels of HBR. uPCR-detected P. vivax infections also clustered within houses. While 286 there was an immediate reduction in blood-stage P. vivax following MDA (evident in Figure 3 Clinical P. vivax episodes occurred more commonly among younger age groups while uPCR-detected 290 infections occurred more commonly among adults. This pattern was previously described in Thai-Burma 291 border populations over two decades ago (Luxemburger et al., 1996) and is likely the result of some 292 level of acquired immunity to P. vivax infections with time. Both adults and children are exposed to 293 similar levels of P. vivax transmission, yet in children the infection is more likely to result in clinical 294 symptoms whereas in adults, many of the infections are likely to become or remain asymptomatic. 295
Clustering of P. falciparum infections across houses occurred for limited periods of time only prior to 296 MDA (Figure 2) . Clustering of P. vivax across houses persisted across time before and after MDA ( Figure  297 3 Individuals with clinical episodes of both P. falciparum and P. vivax were frequently, diagnosed (either 308 before or after experiencing an episode) with asymptomatic infections during blood screenings. The 309 study did not genotype the infections. In this low transmission setting at least a proportion of these 310 associated clinical episodes and uPCR detected infections are likely to have been the same parasite 311 strain, suggestive of long-term carriage of both P. falciparum and P. vivax. This is supported by a large 312
Vietnamese cohort study, showing that 20% of asymptomatic P. falciparum carriers and 59% of P. vivax 313 carriers carry their parasitaemia for 4 months or longer (Chen et al., 2016; Nguyen et al., 2018) . The 314 observation that P. falciparum and P. vivax parasite densities oscillate during long-term Plasmodium 315 carriage suggests that gametocytaemia might also occur in waves, at some point in time sufficient to 316 transmit to a suitable vector. If such infections remain asymptomatic, they are unlikely to be diagnosed 317 and treated through standard early diagnosis and treatment (EDT) approaches. Active approaches for 318 detecting and treating these infections, such as targeted MDA or mass screen and treat, are necessary. 319
There are several limitations to this work. Individuals who did not participate in MDA also did not 320 participate in blood screenings immediately after MDA (i.e. M3 in village TOT). uPCR detected infections 321
are therefore likely to be underdiagnosed for these individuals. There is also evidence of a poorly 322 functioning MP in this village, which could have meant undiagnosed (and therefore unrecorded) clinical 323 episodes, especially during the beginning of the study. Finally, some infections are likely to be acquired 324 outside of the village, leading to complex spatial patterns in infections that are mapped at the house 325 level. Within household clustering can be the result of within house transmission, or shared exposure 326 among household members. 327
CONCLUSION 328
These data suggest that poor MDA adherence in the presence of a significant parasite reservoir and 329 sufficient vector activity, can lead to resurgence of malaria in a matter of months after reduced 330 transmission due to MDA (Figure 5A) . This is especially true in a setting with a poorly functioning 331 diagnosis and treatment center. Conversely, high coverage of MDA in a population can confer benefits 332 long after the prophylactic period has ended -most likely as a result of clearing the parasite reservoir 333 (Table 1, Figure 5A ). Community engagement to maximize community participation, is crucial for MDA 334 success (Kajeechiwa et al., 2017) and villages or portions of villages with poor adherence present 335 persistent challenges to elimination efforts. 336 (blue dots) , and a cluster of non-participation in MDA (grey circle/ochre border, detected using SatScan). Season is indicated by colored squares in the top right corner of each map. A measure of the spread of clinical P. falciparum cases is given by the standard distance deviation ("SD"), indicated by the hollow circle with dark grey outline. One standard deviation is shown, indicating that roughly 68% of all cases lie inside of the circle. Approximately 6 months post-MDA (M9), clinical infections began in the westernmost portion of the village. The distribution of these cases through month 15 corresponds with the cluster of non-MDA participation (indicated by the grey circle in M3). By M24 the cases extended throughout much of the village. Study month was included as a control (a linear specification was used, but polynomial specifications were also tested). An interaction between individual level MDA adherence and neighborhood level adherence was also included as a control.
The human biting rate (HBR) was operationalized as a time-varying covariate with a one month lag. The covariate for having a house member with a clinical episode was also operationalized as a time-varying covariate (coded as "1" for any month in which another house member had a clinical P. falciparum episode and a "0" if no other house members had a clinical episode during that month.) The number of surveys that an individual participated in was included as a control variable. An interaction control variable for individual level MDA adherence and neighborhood adherence was also included in the models. 
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